Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2018 07:00 ET | Source: Artios Pharma Ltd.

Artios exercises option to in-license potential first-in-class nuclease development programme

Artios Pharma Ltd ("Artios" or "the Company") Artios exercises option to in-license potential first-in-class nuclease development programme Cambridge, UK, 5 March 2018. Artios Pharma, a...
February 26, 2018 07:16 ET | Source: Artios Pharma Ltd.

Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors

Artios Pharma Ltd. ("Artios" or "the Company") Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors Industry leader who brings over 35 years of experience in...
September 21, 2016 07:21 ET | Source: Artios Pharma Ltd.

Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies

CAMBRIDGE, United Kingdom, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Artios Pharma Ltd., a new private company focussed on developing novel cancer treatments targeting the DNA Damage Response, was officially...